ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DAVID GORELICK MD

50 MEMORIAL BLVD AQUIDNECK MEDICAL ASSOCIATES, INC

Newport | Rhode Island | 02840

(401) 847-2290

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,845Medicare Part D Prescriptions Filled, Including Refills

Rank: 137 out of 337

$370K Total Retail Price of All Prescriptions

Rank: 123 out of 337

312 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 312 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 312 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 5,414 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LEVOTHYROXINE SODIUM 354 287 1 5
LISINOPRIL 298 247 2 2
AMLODIPINE BESYLATE 276 257 3 3
SIMVASTATIN 255 210 4 1
OMEPRAZOLE 216 119 5 4
PRAVASTATIN SODIUM 162 108 6 14
ATENOLOL 161 161 7 10
ATORVASTATIN CALCIUM 153 128 8 7
CRESTOR 131 87 9 29
LOSARTAN POTASSIUM 131 118 9 15
METOPROLOL TARTRATE 130 130 11 6
FUROSEMIDE 126 99 12 8
HYDROCHLOROTHIAZIDE 124 111 13 9
METFORMIN HCL ER 119 92 14 52
DIOVAN 117 71 15 26
HYDROCODONE-ACETAMINOPHEN 101 91 S3 16 13
ZOLPIDEM TARTRATE 97 97 17 23
FLUOXETINE HCL 93 54 18 57
TAMSULOSIN HCL 86 69 19 25
FLUTICASONE PROPIONATE 84 38 20 34
NEXIUM 83 49 21 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 68 22 31
TRIAMTERENE-HCTZ 78 73 23 39
POTASSIUM CHLORIDE 70 41 24 62
GABAPENTIN 67 54 25 20
PANTOPRAZOLE SODIUM 67 58 25 36
TRAZODONE HCL 63 50 27 16
SERTRALINE HCL 61 52 28 18
CITALOPRAM HBR 60 47 29 17
METFORMIN HCL 59 49 30 12
WARFARIN SODIUM 53 52 31 11
CARVEDILOL 53 36 31 73
EVISTA 51 38 33 102
BENICAR 50 50 34 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.